In recent years, management of hepatitis C virus (HCV) infection has changed dramatically because of the approval of new antiviral therapies. The purpose of the American Society for Blood and Marrow Transplantation (ASBMT) Task Force on HCV infection in hematopoietic cell transplant (HCT) recipients is to provide guidance regarding diagnosis and management of HCV infection in donors and recipients of hematopoietic cells.
No takes yet. Share an insight, caveat, or question.
Torres et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: